Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer Beavis"'
Publikováno v:
Renal Society of Australasia Journal. 17
Autor:
Peter G. Kerr, Matthew J Damasiewicz, Nigel David Toussaint, Kevan R. Polkinghorne, S. Heinze, Eugenie Pedagogos, Kenneth K. Lau, Jennifer Beavis, Gavin J. Becker
Publikováno v:
Nephrology. 16:389-395
Aim: Vascular calcification is prevalent in patients with chronic kidney disease. Abdominal aortic calcification (AAC) can be detected by X-ray, although AAC is less well documented in anatomical distribution and severity compared with coronary calci
Publikováno v:
Nephron Clinical Practice. 113:c38-c45
Background/Aims: Many hemodialysis patients receive antiplatelet therapy or warfarin; however, little is known about the effect of this on iron requirements. Given the association of antiplatelet therapy with bleeding we hypothesized that there shoul
Publikováno v:
BMC Nephrology
Background Phosphate binders’ constituents have alkalotic or acidotic properties and may contribute to acid base balance in haemodialysis patients. This study aimed to investigate the differential effects of phosphate binders on pre-dialysis serum
Autor:
Nigel D, Toussaint, Eugenie, Pedagogos, Kenneth K, Lau, Stefan, Heinze, Gavin J, Becker, Jennifer, Beavis, Kevan R, Polkinghorne, Matthew J, Damasiewicz, Peter G, Kerr
Publikováno v:
Nephrology (Carlton, Vic.). 16(4)
Vascular calcification is prevalent in patients with chronic kidney disease. Abdominal aortic calcification (AAC) can be detected by X-ray, although AAC is less well documented in anatomical distribution and severity compared with coronary calcificat
Autor:
Eugenie Pedagogos, Nigel D Toussaint, Gavin J. Becker, Peter G. Kerr, Jennifer Beavis, Kevan R. Polkinghorne
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 26(4)
Background Although clinical guidelines exist for optimal levels of serum markers of chronic kidney disease mineral and bone disorder (CKD-MBD), target parameters are not achieved in many haemodialysis (HD) patients. The reason for this evidence-prac